The Gary Null Show - 10.24.22

The Gary Null Show - A podcast by Progressive Radio Network

Videos: The Old World Order Is About To Collapse – Peter Zeihan | Modern Wisdom Podcast 514 (0:20 to 20:00) Tulsi Gabbard Speech LIVE | Tulsi Gabbard Accuses Joe Biden | US News Latest | English News LIVE Noam Chomsky – The Crimes of U.S. Presidents Clare Daly Latest Top 7 Contributions in the EU. (First 1 of 7 ) (start @ 0:17)   Carotenoids linked to lower diabetesUtrecht University Medical Center (Netherlands), October 21, 2022 A prospective study of 37,846 subjects links higher carotenoid consumption to a lower risk of diabetes. People who consume a diet high in antioxidant-rich carotenoids have a lower occurrence of diabetes, according to a new study. The researchers linked higher intakes of beta and alpha carotene with lower risks of type 2 diabetes. The research analyzed data from validated food frequency questionnaires from 37,846 participants in the European Prospective Investigation into Cancer and Nutrition, which followed subjects for a mean of 10 years. They focused on dietary carotenoid intake levels consisting of beta-carotene, alpha-carotene, beta-cryptoxanthin, lycopene, lutein, zeaxanthin and the total of these six carotenoids. The study also examined how smoking (tobacco, not carotenoids) played into the subjects’ risk of developing diabetes. Thirty-one percent of the subjects smoked. “This study shows that diets high in beta-carotene and alpha-carotene are associated with reduced type 2 diabetes in generally healthy men and women,” concluded the authors of the study, which appeared in the journal Nutrition, Metabolism & Cardiovascular Disease. Smoking, according the researchers’ analysis, made no difference in the risk of diabetes. An earlier study linked low carotenoids with increased risk of colon cancer. Animal and human studies have found that beta-carotene can enhance many aspects of immunity. Some of this research has shown that beta-carotene boosts the activity of “natural-killer” cells, a type of immune cell that fights cancer. Melatonin and CoQ10 for migrainesUniversity of California, Los Angeles, October 20, 2022 Migraines affect about 12 percent of people in the United States, occurring more often in women, in people between the ages of 30 and 39, and within families. A retrospective analysis of migraine sufferers found that emotional stress was a trigger for 80 percent of them, missing a meal was a trigger for 57 percent, and lack of sleep was a trigger for 50 percent. In a study, patients who experienced migraine headaches two to eight times per month were randomly assigned to take either a placebo or 100 milligrams of CoQ10 three times per day for at least three months. The authors measured success as a greater than 50 percent reduction in the frequency of migraines. Only 14.4 percent of those who took the placebo showed this level of reduction, but 47.6 percent of those who took CoQ10 reduced their frequency of migraines by that amount. Then there’s the B vitamin riboflavin. Another study found that 59 percent of people who took a daily dose of 400 milligrams had a greater than 50 percent reduction in the frequency of migraines, compared to 15 percent of those who took a placebo. However, it took three months for riboflavin to show this benefit. Knowing that sleep problems increase the risk of migraines, researchers compared the effects of 3 milligrams of melatonin to the effects of the anti-depressant amitriptyline or of a placebo. After three months, 54.4 percent of people who took melatonin had a 50 percent or greater reduction in frequency of headaches compared to 39.1 percent in the amitriptyline group and 20 percent in the placebo group. Study: Eating foods high in healthy fats helps fight off skin cancerUniversity Medical Center Groningen (Netherlands), October 21, 2022 A study has found that foods rich in healthy fats can help protect against skin cancer and boost the effectiveness of immunotherapy among skin cancer patients. Results showed that patients who followed the Me

Visit the podcast's native language site